Public Health Product Hops
Bill of Health
APRIL 24, 2023
Regulatory and patent exclusivity periods govern the timing of generic entry, and because market share and revenue is often quickly lost upon market entry of generic drugs, extending market exclusivity for any duration can be extremely profitable. But perhaps other forms of public health benefit would outweigh these harms?
Let's personalize your content